Eli Lilly and Co (LLY)

Add to Watchlists
Create an Alert
Quickflows
201.93 -2.21  -1.08% NYSE Mar 3, 16:59 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All LLY News

News

View All Events

Events

Date Type Description
04/27/2021 Earnings Eli Lilly and Co First Quarter Earnings Result for 2021
04/27/2021 09:00 EDT Misc Eli Lilly and Co First Quarter Earnings Conference Call for 2021
02/11/2021 Dividends Amount: 0.85, Declared Date: Dec 14 2020, Pay Date: Mar 10 2021
01/29/2021 Earnings Eli Lilly and Co Fourth Quarter Earnings Result for 2020
01/29/2021 09:00 EST Misc Eli Lilly and Co Fourth Quarter Earnings Conference Call for 2020
11/12/2020 Dividends Amount: 0.74, Declared Date: Oct 19 2020, Pay Date: Dec 10 2020
10/27/2020 09:00 EDT Misc Eli Lilly and Co Third Quarter Earnings Conference Call for 2020
10/27/2020 Earnings Eli Lilly and Co Third Quarter Earnings in 2020 Release
08/13/2020 Dividends Amount: 0.74, Declared Date: Jul 15 2020, Pay Date: Sep 10 2020
07/30/2020 09:00 EDT Misc Eli Lilly and Co Second Quarter Earnings Conference Call for 2020
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 24.54B
Total Expenses (TTM) 17.69B
Net Income (TTM) 6.194B

Balance Sheet View Statement

Total Assets (Quarterly) 46.63B
Total Liabilities (Quarterly) 40.81B
Shareholders Equity (Quarterly) 5.642B

Cash Flow Statement View Statement

Cash from Operations (TTM) 6.500B
Cash from Investing (TTM) -2.259B
Cash from Financing (TTM) -3.137B

Ratings & Reports

Advertisement
Edit

Profile

  • URL: https://www.lilly.com
  • Investor Relations URL: https://investor.lilly.com/
  • HQ State/Province: Indiana
  • Sector: Healthcare
  • Industry: Drug Manufacturers - General
  • Equity Style: Large Cap/Blend
  • Next Earnings Release: Apr. 27, 2021
  • Last Earnings Release: Jan. 29, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Feb. 11, 2021
  • Description: Eli Lilly is a drug company with a focus on neuroscience, endocrinology, oncology, and immunology. Lilly's key products include Alimta and Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 201.93
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
VPMCX Vanguard PRIMECAP Inv 4.92%
VHCOX Vanguard Capital Opportunity Inv 4.10%
VGHCX Vanguard Health Care Inv 3.94%
XLV Health Care Select Sector SPDR® ETF 3.78%
VHT Vanguard Health Care ETF 3.32%
VEIPX Vanguard Equity-Income Inv 1.86%
USMV iShares MSCI USA Min Vol Factor ETF 1.60%
VHYAX Vanguard High Dividend Yield Index Adm 1.59%
VYM Vanguard High Dividend Yield ETF 1.59%
VIVAX Vanguard Value Index Inv 1.26%
VTV Vanguard Value ETF 1.01%
IWF iShares Russell 1000 Growth ETF 0.94%

Comparables

Edit
REGN Regeneron Pharmaceuticals Inc
MRNA Moderna Inc
VIR Vir Biotechnology Inc
AMGN Amgen Inc
BIIB Biogen Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.